Welcome
New Home-Mid Content
WELCOME
The King's Thrombosis Centre is a leading multidisciplinary clinical and research group dedicated to the diagnosis and treatment of hypercoagulable conditions.
We are a designated Haemophilia Centre and were the first National Venous Thromboembolism (VTE) Exemplar Centre, reflecting our national leadership in the prevention and treatment of VTE. Our clinical trials unit works in partnership with industry to develop new treatments for VTE prevention and treatment.
THE FIRST REGISTRY
With the next generation of oral anticoagulants entering clinical practice, the FIRST registry will provide an important data tool to increase knowledge and improve the quality of care of patients with VTE.
King's Thrombosis Centre COVID-19 Research
Clinicians and researchers in the King’s Thrombosis Centre are completing a number of research studies relating to the COVID-19 pandemic.
Click here to view the latest publications from our centre, relating to this.
Click here to view the BBC interview with Prof Roopen Arya on thrombosis in COVID-19.
VTE EXEMPLAR CENTRE NETWORK WEBSITE
After being hosted at the King's Thrombosis Centre website since its launch in 2007, the website is now managed as part of the National VTE prevention Programme at NHS England. Click here to access the site.
Latest News
-
Anticoagulation news items. Weeks commencing 22nd and 29th November 2021
Mechanism suggested for development of rare blood clots with AstraZeneca covid 19 vaccine Science AdvancesThis rare syndrome resembling heparin-induced thrombocytopenia (HIT), has been observed with ChAdOx1 (AZ) vaccine. Computational simulation…
-
Anticoagulation news items. Week commencing 15th November 2021
Milvexian for the Prevention of Venous Thromboembolism New England Journal of MedicineIn this Phase II study of patients undergoing knee arthroplasty (n=1242), the oral factor XIa inhibitor milvexian was associated…
-
Anticoagulation news items. Week commencing 8th November 2021
Tranexamic acid in gastrointestinal bleeding: A systematic review and meta-analysis Critical Care MedicineSystematic review (12 RCT's) found extended-use high-dose IV tranexamic acid did not improve mortality or bleeding risk &…
